Raltegravir: is a 400 mg once-daily dose enough?

Massimiliano Lanzafame; Andrew Hill; Emanuela Lattuada; Andrea CALCAGNO; Stefano BONORA

doi:10.1093/jac/dkp488

Raltegravir: is a 400 mg once-daily dose enough?

Massimiliano Lanzafame
, Andrew Hill
, Emanuela Lattuada
, Andrea CALCAGNO
, Stefano BONORA

Department of Translational Medicine

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	595-597
Number of pages	3
Journal	Journal of Antimicrobial Chemotherapy
Volume	65 (3)
DOIs	https://doi.org/10.1093/jac/dkp488
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

HIV
treatment
raltegravir
pharmacokinetics

Access to Document

10.1093/jac/dkp488

https://hdl.handle.net/11579/217016

Cite this

@article{0cbe698bdbc041a1977d0b178abb986a,

title = "Raltegravir: is a 400 mg once-daily dose enough?",

keywords = "HIV, treatment, raltegravir, pharmacokinetics, HIV, treatment, raltegravir, pharmacokinetics",

author = "Massimiliano Lanzafame and Andrew Hill and Emanuela Lattuada and Andrea CALCAGNO and Stefano BONORA",

year = "2010",

doi = "10.1093/jac/dkp488",

language = "English",

volume = "65 (3)",

pages = "595--597",

journal = "Journal of Antimicrobial Chemotherapy",